CIK 0001652130
- Large accelerated filer
Intellia Therapeutics, Inc.
Sign in to watch- Ticker
- NTLA
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 364785571
- Phone
- +1 857-285-6200
- Business address
- 400 TECHNOLOGY SQUARE, SUITE 100, CAMBRIDGE, MA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $417,899
- in 3 filings, $395K under 10b5-1 plans
Net −$417,899. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-02 | BASTA JAMES EVP, General Counsel | Sale | −1,211 | $13.78 | $17K | 156,794 |
| 2026-03-01 | BASTA JAMES EVP, General Counsel | Grant or award | +46,080 | 158,005 | ||
| 2026-03-01 | BASTA JAMES EVP, General Counsel | Grant or award · Stock Option (right to buy) | +65,829 | 65,829 | ||
| 2026-01-05 | BASTA JAMES EVP, General Counsel | Sale | −10,397 | $9.21 | $96K | 101,528 |
| 2025-03-04 | BASTA JAMES EVP, General Counsel | Sale | −2,572 | $8.99 | $23K | 111,925 |
| 2025-03-01 | BASTA JAMES EVP, General Counsel | Grant or award | +40,000 | 114,497 | ||
| 2025-03-01 | BASTA JAMES EVP, General Counsel | Grant or award · Stock Option (right to buy) | +57,143 | 57,143 | ||
| 2025-01-03 | BASTA JAMES EVP, General Counsel | Sale | −7,074 | $12.18 | $86K | 74,497 |
| 2024-03-04 | BASTA JAMES EVP, General Counsel | Sale | −2,297 | $32.99 | $76K | 81,571 |
| 2024-03-01 | BASTA JAMES EVP, General Counsel | Grant or award | +32,394 | 83,868 | ||
| 2024-03-01 | BASTA JAMES EVP, General Counsel | Grant or award · Stock Option (right to buy) | +46,752 | 46,752 | ||
| 2024-01-03 | BASTA JAMES EVP, General Counsel | Sale | −3,805 | $29.46 | $112K | 51,474 |
| 2023-03-02 | BASTA JAMES EVP, General Counsel | Sale | −1,088 | $43.88 | $48K | 55,279 |
| 2023-03-01 | BASTA JAMES EVP, General Counsel | Grant or award | +24,539 | 44,098 | ||
| 2023-03-01 | BASTA JAMES EVP, General Counsel | Grant or award | +12,269 | 56,367 | ||
| 2023-03-01 | BASTA JAMES EVP, General Counsel | Grant or award · Stock Option (right to buy) | +34,674 | 34,674 | ||
| 2023-01-04 | BASTA JAMES EVP, General Counsel | Sale | −1,138 | $37.21 | $42K | 19,559 |
| 2022-03-01 | BASTA JAMES EVP, General Counsel | Grant or award · Stock Option (right to buy) | +14,109 | 14,109 | ||
| 2022-03-01 | BASTA JAMES EVP, General Counsel | Grant or award | +11,049 | 11,049 | ||
| 2022-03-01 | BASTA JAMES EVP, General Counsel | Grant or award | +9,648 | 20,697 |
Page 1 of 2 · 22 trades